When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALLK - Allakos' antolimab shows encouraging action in early-stage study
Allakos Inc.
Allakos (NASDAQ:ALLK) announces positive results from an open-label Phase 1 clinical trial evaluating lead candidate antolimab in seven patients with moderate-to-severe gastrointestinal symptoms and elevated mast cells associated with mast cell gastrointestinal disease (MGID).
More news on: Allakos Inc., Healthcare stocks news, Stocks on the move,